Dexcom announced on Tuesday the introduction of an artificial intelligence feature for its Stelo continuous glucose monitor (CGM), offering users personalized insights into how meals, sleep, and activity affect their glucose levels. This marks the first iteration of a new generative AI platform developed in collaboration with Google Cloud.
Overview of Stelo CGM
Stelo, which launched in August, is an over-the-counter CGM designed for adults who do not take insulin. The device measures real-time blood sugar levels through a sensor that penetrates the skin, aiming to provide a user-friendly experience for those managing their glucose levels with no medication.
Enhancing User Experience
As Dexcom seeks to engage consumers in this new market, the company is focused on making the Stelo experience more personalized. Jake Leach, Dexcom’s Chief Operating Officer, emphasized the importance of user feedback, stating, “The No. 1 feedback we get is users want to see more.” With this AI feature, users will maximize the value of the data generated by their CGMs.
AI Technology and Capabilities
The new AI feature utilizes Google’s Gemini models and Vertex AI platform, which enables the synthesis of diverse data types—an often complex challenge in healthcare.
Personalized Insights
While Stelo users previously received standard weekly insights, the new AI-generated reports will offer tailored recommendations. For example, if a user fails to engage in sufficient physical activity after meals, the report will provide relevant tips and educational materials to help improve their habits.
Importantly, the AI reports do not offer medical advice, although Dexcom is developing the feature in alignment with an AI framework approved by the U.S. Food and Drug Administration (FDA). Stelo itself received FDA approval in March.
Future Developments
Dexcom aims to evolve its generative AI platform to deliver real-time feedback to users, moving beyond weekly reports. The company is also exploring the potential for the AI technology to serve as a predictive tool for identifying potential health issues, akin to a vehicle’s check engine light.
Chris Sakalosky, Vice President of Strategic Industries for Google Cloud, noted that the AI feature could provide users with insights about their health and recommendations for seeking further advice.
Conclusion
The rollout of the AI-enhanced weekly report for Stelo users began this week, marking a significant advancement in personalized healthcare technology. With this new feature, Dexcom aims to empower users to take control of their health through actionable insights, ultimately enhancing their overall experience with the Stelo CGM.
